Organ Preservation in Multimodality Therapy of Head and Neck Cancer
- 1 August 1991
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 5 (4) , 713-724
- https://doi.org/10.1016/s0889-8588(18)30411-8
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Response to chemotherapy as justification for modification of the therapeutic strategy for pharyngolaryngeal carcinomasHead & Neck, 1990
- Preoperative chemotherapy in advanced resectable head and neck cancer: Final report of the southwest oncology groupThe Laryngoscope, 1988
- Cisplatin and Fluorouracil as Neoadjuvant Therapy in Head and Neck Cancer: A Preliminary ReportJAMA Otolaryngology–Head & Neck Surgery, 1987
- The effects of delay in standard treatment due to induction chemotherapy in two randomized prospective studiesThe Laryngoscope, 1987
- Cis-platinum and 5-fluorouracil as induction therapy for advanced head and neck cancerThe American Journal of Surgery, 1982
- Improved survival for patients with advanced carcinoma of the head and neck treated with methotrexate‐leucovorin prior to definitive radiotherapy or surgery.The Laryngoscope, 1981
- Management of T3 Glottic CancerJAMA Otolaryngology–Head & Neck Surgery, 1980
- Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized studyAmerican Journal of Roentgenology, 1976
- High dose methotrexate as a preoperative adjuvant in the treatment of epidermoid carcinoma of the head and neck: A feasibility study and clinical trialThe American Journal of Surgery, 1975
- Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum ElectrodeNature, 1965